Riesgo de interrupción del ticagrelor frente al clopidogrel. Respuesta / Risk of ticagrelor versus clopidogrel discontinuation. Response
Rev. esp. cardiol. (Ed. impr.)
; 77(4): 356-357, abr2024.
Article
in Spanish
| IBECS
| ID: ibc-232203
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Cardiology
/
Acute Coronary Syndrome
/
Purinergic P2Y Receptor Antagonists
/
Clopidogrel
/
Ticagrelor
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. esp. cardiol. (Ed. impr.)
Year:
2024
Document type:
Article
Institution/Affiliation country:
Hospital Universitario Virgen Macarena/España